Hypothesising Mechanism-Based Inhibition (MBI) of mutant IDH1.

First Iteration of a working theory on use of MBIs on IDH1 mutant enzymes to investigate potential therapies against a certain type of Leukemia

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-08-20
DOI
https://doi.org/10.5281/zenodo.22019568
Primary Topic
Ubiquitin and proteasome pathways
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypothesising Mechanism-Based Inhibition (MBI) of mutant IDH1.

Harry Jansen
Zenodo (CERN European Organization for Nuclear Research)
Ubiquitin and proteasome pathways
article

Hypothesising Mechanism-Based Inhibition (MBI) of mutant IDH1.

Harry Jansen
article en

Abstract

First Iteration of a working theory on use of MBIs on IDH1 mutant enzymes to investigate potential therapies against a certain type of Leukemia

Zenodo (CERN European Organization for Nuclear Research)
Mexican American Catholic College (US)
Openalex Percentile: Top 16%
Ubiquitin and proteasome pathways
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Hypothesising Mechanism-Based Inhibition (MBI) of mutant IDH1. — Harry Jansen · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS